Opiorphin vs Spinorphin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Opiorphin is a five-amino acid peptide (QRFSR) discovered in human saliva by Catherine Rougeot at the Pasteur Institute in 2006. It is an endogenous inhibitor of neutral endopeptidase (NEP/neprilysin) and aminopeptidase N (APN), two enzymes that rapidly degrade enkephalins in the...
Calculate Opiorphin dose →Spinorphin is a 10-amino acid peptide (LVVYPWTQRF) isolated from bovine spinal cord by Nishizawa et al. 11 (neprilysin, NEP), functioning as an indirect opioid amplifier similar to opiorphin....
Calculate Spinorphin dose →| Parameter | Opiorphin | Spinorphin |
|---|---|---|
| Category | Opioid-Modulating Peptide | Opioid-Modulating Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | < 5 min (plasma) | < 10 min (plasma) |
| Typical Dose | Research only (mg/kg range) | Research only (mg/kg range) |
| Frequency | N/A | N/A |
| Route | IV, SC (research) | IV, ICV (research) |
| FDA Status | No approval | No approval |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.